224 related articles for article (PubMed ID: 28380322)
1. Vitamin D in amyotrophic lateral sclerosis.
Libonati L; Onesti E; Gori MC; Ceccanti M; Cambieri C; Fabbri A; Frasca V; Inghilleri M
Funct Neurol; 2017; 32(1):35-40. PubMed ID: 28380322
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis.
Karam C; Barrett MJ; Imperato T; MacGowan DJ; Scelsa S
J Clin Neurosci; 2013 Nov; 20(11):1550-3. PubMed ID: 23815870
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D is Not a Protective Factor in ALS.
Blasco H; Madji Hounoum B; Dufour-Rainfray D; Patin F; Maillot F; Beltran S; Gordon PH; Andres CR; Corcia P
CNS Neurosci Ther; 2015 Aug; 21(8):651-6. PubMed ID: 26096806
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis.
Paganoni S; Macklin EA; Karam C; Yu H; Gonterman F; Fetterman KA; Cudkowicz M; Berry J; Wills AM
Muscle Nerve; 2017 Oct; 56(4):726-731. PubMed ID: 28044349
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation has no effects on progression of motor dysfunction in amyotrophic lateral sclerosis (ALS).
Trojsi F; Siciliano M; Passaniti C; Bisecco A; Russo A; Lavorgna L; Esposito S; Ricciardi D; Monsurrò MR; Tedeschi G; Santangelo G
Eur J Clin Nutr; 2020 Jan; 74(1):167-175. PubMed ID: 31197218
[TBL] [Abstract][Full Text] [Related]
6. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
[TBL] [Abstract][Full Text] [Related]
7. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
8. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
[TBL] [Abstract][Full Text] [Related]
9. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
Pinto S; de Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
[TBL] [Abstract][Full Text] [Related]
10. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D levels are not predictors of survival in a clinic population of patients with ALS.
Yang J; Park JS; Oh KW; Oh SI; Park HM; Kim SH
J Neurol Sci; 2016 Aug; 367():83-8. PubMed ID: 27423568
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology analysis and clinical efficacy of the traditional Chinese medicine Bu-Shen-Jian-Pi. Part 3: Alleviation of hypoxia, muscle-wasting, and modulation of redox functions in amyotrophic lateral sclerosis.
Li R; Han X; Wang Q; Wang C; Jing W; Zhang H; Wang J; Pan W
Int J Clin Pharmacol Ther; 2024 Apr; 62(4):169-177. PubMed ID: 38431830
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study.
de la Rubia JE; Drehmer E; Platero JL; Benlloch M; Caplliure-Llopis J; Villaron-Casales C; de Bernardo N; AlarcÓn J; Fuente C; Carrera S; Sancho D; GarcÍa-Pardo P; Pascual R; JuÁrez M; Cuerda-Ballester M; Forner A; Sancho-Castillo S; Barrios C; Obrador E; Marchio P; Salvador R; Holmes HE; Dellinger RW; Guarente L; Estrela JM
Amyotroph Lateral Scler Frontotemporal Degener; 2019 Feb; 20(1-2):115-122. PubMed ID: 30668199
[TBL] [Abstract][Full Text] [Related]
14. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
15. Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis.
Hu N; Shen D; Yang X; Cui L; Liu M
J Clin Neurosci; 2022 Mar; 97():93-98. PubMed ID: 35074582
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
17. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
Pastula DM; Moore DH; Bedlack RS
Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
[TBL] [Abstract][Full Text] [Related]
18. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).
Qureshi MM; Hayden D; Urbinelli L; Ferrante K; Newhall K; Myers D; Hilgenberg S; Smart R; Brown RH; Cudkowicz ME
Amyotroph Lateral Scler; 2006 Sep; 7(3):173-82. PubMed ID: 16963407
[TBL] [Abstract][Full Text] [Related]
19. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes.
Elamin EM; Wilson CS; Sriaroon C; Crudup B; Pothen S; Kang YC; White KT; Anderson WM
Int J Clin Pract; 2019 Jan; 73(1):e13257. PubMed ID: 30230161
[TBL] [Abstract][Full Text] [Related]
20. Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis.
Lanznaster D; Bejan-Angoulvant T; Gandía J; Blasco H; Corcia P
Front Neurol; 2020; 11():697. PubMed ID: 32849187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
